阻塞性睡眠呼吸暂停治疗与血压:哪些表型预测反应?系统综述与荟萃分析
该系统综述与荟萃分析纳入68项RCT,评估CPAP或下颌前移装置(MAD)对血压的影响。汇总分析显示CPAP和MAD分别降低收缩压约2.09 mmHg和1.27 mmHg,舒张压约1.92 mmHg和1.11 mmHg。年龄<60岁、基线血压未控制及严重氧减(最低SpO2<77%)的患者血压下降更显著。
要点
- CPAP和MAD对OSA患者血压的总体降低幅度较小。
- 年龄<60岁、基线血压未控制、严重氧减者血压反应更明显。
- 需谨慎解读,但有助于识别可能从治疗中血压获益的表型。
核心结论
- CPAP或MAD治疗OSA对血压的预期降低幅度有限,但特定表型患者可能获得更明显的血压控制获益。
研究设计与样本
- 系统综述与荟萃分析,检索三个数据库,从2289篇文章中纳入68项比较CPAP或MAD与被动或主动治疗的随机对照试验(RCT)。
主要发现
- 汇总所有研究,CPAP与收缩压平均降低-2.09(95%CI -2.78至-1.40)mmHg、舒张压降低-1.92(95%CI -2.40至-1.43)mmHg相关。
- MAD与收缩压平均降低-1.27(95%CI -2.34至-0.20)mmHg、舒张压降低-1.11(95%CI -1.82至-0.41)mmHg相关。
- 年龄<60岁患者收缩压降低-2.93 mmHg,基线血压未控制者收缩压降低-4.14 mmHg,基线严重氧减(最低SpO2<77%)者24小时收缩压降低-7.57 mmHg。
临床怎么用
- 对OSA患者选择CPAP或MAD治疗时,可结合年龄、基线血压控制情况及夜间氧减程度预判血压获益。
局限性
- 作者指出这些发现应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP) or mandibular advancement devices (MADs) is associated with blood pressure (BP) reduction; however, the overall effect is modest. The aim of this systematic review and meta-analysis of randomised controlled trials (RCTs) comparing the effect of such treatments on BP was to identify subgroups of patients who respond best to treatment.The article search was performed in three different databases with specific search terms and selection criteria. From 2289 articles, we included 68 RCTs that compared CPAP or MADs with either passive or active treatment. When all the studies were pooled together, CPAP and MADs were associated with a mean BP reduction of -2.09 (95% CI -2.78- -1.40) mmHg for systolic BP and -1.92 (95% CI -2.40- -1.43) mmHg for diastolic BP and -1.27 (95% CI -2.34- -0.20) mmHg for systolic BP and -1.11 (95% CI -1.82- -0.41) mmHg for diastolic BP, respectively. The subgroups of patients who showed a greater response were those aged <60 years (systolic BP -2.93 mmHg), with uncontrolled BP at baseline (systolic BP -4.14 mmHg) and with severe oxygen desaturations (minimum arterial oxygen saturation measured by pulse oximetry <77%) at baseline (24-h systolic BP -7.57 mmHg).Although this meta-analysis shows that the expected reduction of BP by CPAP/MADs is modest, it identifies specific characteristics that may predict a pronounced benefit from CPAP in terms of BP control. These findings should be interpreted with caution; however, they are particularly important in identifying potential phenotypes associated with BP reduction in patients treated for OSA.
引用
- Pengo MF, Soranna D, Giontella A, et al. Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis. Eur Respir J. 2020. PMID: 32079643. doi:10.1183/13993003.01945-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。